Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients
St. Jude Children’s Research Hospital investigators report promising preliminary results at the annual meeting of ASCO for an experimental monoclonal antibody when combined with chemotherapy for newly diagnosed patients.
Go to Source